Michael R. Bristow
MACOM (United States)(US)University of Colorado Boulder(US)ARCA Biopharma (United States)(US)University of Colorado Anschutz Medical Campus(US)University of Colorado Denver(US)
Publications by Year
Research Areas
Heart Failure Treatment and Management, Cardiac electrophysiology and arrhythmias, Receptor Mechanisms and Signaling, Cardiovascular Function and Risk Factors, Cardiac pacing and defibrillation studies
Most-Cited Works
- → Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure(2004)5,793 cited
- → The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure(1996)4,659 cited
- → Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies(1996)3,446 cited
- → Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts(1982)2,267 cited
- → Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.(1986)1,316 cited
- → Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart Failure